HK Stock MarketDetailed Quotes

02348 DAWNRAYS PHARMA

Watchlist
  • 1.120
  • +0.010+0.90%
Not Open Sep 13 16:08 CST
1.68BMarket Cap2.73P/E (TTM)

DAWNRAYS PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-11.15%577.45M
-9.90%1.15B
4.24%649.92M
9.66%1.28B
2.45%623.48M
13.75%1.17B
24.46%608.59M
7.82%1.02B
-0.36%488.99M
0.11%950.01M
Operating income
-11.15%577.45M
-9.90%1.15B
4.24%649.92M
9.66%1.28B
2.45%623.48M
13.75%1.17B
24.46%608.59M
7.82%1.02B
-0.36%488.99M
0.11%950.01M
Cost of sales
16.85%-239.54M
-1.09%-509.63M
-24.60%-288.07M
-4.18%-504.13M
1.83%-231.2M
-2.17%-483.89M
-5.01%-235.5M
-14.36%-473.63M
-14.61%-224.26M
-17.02%-414.14M
Operating expenses
16.85%-239.54M
-1.09%-509.63M
-24.60%-288.07M
-4.18%-504.13M
1.83%-231.2M
-2.17%-483.89M
-5.01%-235.5M
-14.36%-473.63M
-14.61%-224.26M
-17.02%-414.14M
Gross profit
-6.62%337.91M
-17.07%641.52M
-7.76%361.85M
13.55%773.55M
5.14%392.28M
23.72%681.26M
40.93%373.09M
2.76%550.65M
-10.28%264.74M
-9.94%535.87M
Selling expenses
0.13%-68.91M
-3.02%-147.05M
12.58%-69M
-30.91%-142.73M
-9.23%-78.93M
-99.79%-109.03M
-83.06%-72.26M
35.66%-54.57M
24.63%-39.48M
20.63%-84.81M
Administrative expenses
8.50%-54.15M
7.25%-113.21M
-9.20%-59.18M
-3.96%-122.06M
-0.85%-54.2M
-7.49%-117.41M
-6.87%-53.74M
-12.50%-109.22M
-13.25%-50.28M
-16.71%-97.09M
Research and development expenses
-42.66%-43.88M
-14.26%-90.81M
-2.67%-30.76M
-18.57%-79.48M
-6.45%-29.96M
-15.68%-67.03M
-22.52%-28.15M
---57.94M
---22.97M
----
Operating interest expense
----
----
----
----
-46.10%-225K
86.72%-641K
---154K
9.06%-4.83M
----
-360.85%-5.31M
Special items of operating profit
170.57%392.14M
131.82%165.52M
746.72%144.93M
-27.57%71.4M
81.90%17.12M
279.30%98.59M
-59.82%9.41M
214.31%25.99M
585.35%23.42M
-89.28%-22.74M
Operating profit
61.89%563.11M
-8.93%455.98M
41.35%347.84M
3.08%500.68M
7.84%246.08M
38.76%485.74M
30.09%228.2M
7.41%350.07M
-9.33%175.43M
-16.82%325.92M
Financing cost
-698.80%-2.66M
-166.58%-989K
---333K
---371K
----
----
----
----
-253.62%-3.56M
----
Share of profits of associates
81.79%-3.7M
33.88%-40.93M
0.95%-20.3M
-33.36%-61.91M
-19.69%-20.49M
-147.29%-46.42M
-71.91%-17.12M
-58.69%-18.77M
-80.63%-9.96M
15.80%-11.83M
Earning before tax
70.15%556.75M
-5.55%414.06M
45.05%327.21M
-0.21%438.41M
6.87%225.59M
32.61%439.32M
30.37%211.08M
5.48%331.3M
-13.40%161.91M
-16.86%314.09M
Tax
10.78%-65.17M
-10.70%-91.39M
-35.85%-73.04M
3.06%-82.56M
-18.45%-53.77M
-28.05%-85.16M
-32.13%-45.39M
-13.22%-66.51M
5.99%-34.35M
20.43%-58.74M
After-tax profit from continuing operations
93.41%491.58M
-9.33%322.67M
47.92%254.17M
0.48%355.85M
3.70%171.83M
33.75%354.16M
29.90%165.69M
3.70%264.79M
-15.20%127.55M
-15.99%255.36M
Earning after tax
93.41%491.58M
-9.33%322.67M
47.92%254.17M
0.48%355.85M
3.70%171.83M
33.75%354.16M
29.90%165.69M
3.70%264.79M
-15.20%127.55M
-15.99%255.36M
Minority profit
17.39%-1.46M
-51.09%-3.33M
-1,173.33%-1.77M
45.01%-2.21M
117.28%165K
-20.23%-4.01M
55.35%-955K
-4,409.46%-3.34M
---2.14M
---74K
Profit attributable to shareholders
92.64%493.05M
-8.95%326M
49.10%255.94M
-0.03%358.06M
3.01%171.66M
33.58%358.18M
28.49%166.65M
4.97%268.13M
-13.78%129.69M
-15.97%255.43M
Basic earnings per share
92.50%0.3286
-9.00%0.2174
48.95%0.1707
-0.13%0.2389
2.96%0.1146
37.79%0.2392
33.13%0.1113
7.09%0.1736
-11.91%0.0836
-15.40%0.1621
Diluted earnings per share
92.83%0.3282
-8.94%0.217
48.91%0.1702
0.34%0.2383
3.07%0.1143
36.89%0.2375
32.66%0.1109
7.03%0.1735
-11.91%0.0836
-15.40%0.1621
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover -11.15%577.45M-9.90%1.15B4.24%649.92M9.66%1.28B2.45%623.48M13.75%1.17B24.46%608.59M7.82%1.02B-0.36%488.99M0.11%950.01M
Operating income -11.15%577.45M-9.90%1.15B4.24%649.92M9.66%1.28B2.45%623.48M13.75%1.17B24.46%608.59M7.82%1.02B-0.36%488.99M0.11%950.01M
Cost of sales 16.85%-239.54M-1.09%-509.63M-24.60%-288.07M-4.18%-504.13M1.83%-231.2M-2.17%-483.89M-5.01%-235.5M-14.36%-473.63M-14.61%-224.26M-17.02%-414.14M
Operating expenses 16.85%-239.54M-1.09%-509.63M-24.60%-288.07M-4.18%-504.13M1.83%-231.2M-2.17%-483.89M-5.01%-235.5M-14.36%-473.63M-14.61%-224.26M-17.02%-414.14M
Gross profit -6.62%337.91M-17.07%641.52M-7.76%361.85M13.55%773.55M5.14%392.28M23.72%681.26M40.93%373.09M2.76%550.65M-10.28%264.74M-9.94%535.87M
Selling expenses 0.13%-68.91M-3.02%-147.05M12.58%-69M-30.91%-142.73M-9.23%-78.93M-99.79%-109.03M-83.06%-72.26M35.66%-54.57M24.63%-39.48M20.63%-84.81M
Administrative expenses 8.50%-54.15M7.25%-113.21M-9.20%-59.18M-3.96%-122.06M-0.85%-54.2M-7.49%-117.41M-6.87%-53.74M-12.50%-109.22M-13.25%-50.28M-16.71%-97.09M
Research and development expenses -42.66%-43.88M-14.26%-90.81M-2.67%-30.76M-18.57%-79.48M-6.45%-29.96M-15.68%-67.03M-22.52%-28.15M---57.94M---22.97M----
Operating interest expense -----------------46.10%-225K86.72%-641K---154K9.06%-4.83M-----360.85%-5.31M
Special items of operating profit 170.57%392.14M131.82%165.52M746.72%144.93M-27.57%71.4M81.90%17.12M279.30%98.59M-59.82%9.41M214.31%25.99M585.35%23.42M-89.28%-22.74M
Operating profit 61.89%563.11M-8.93%455.98M41.35%347.84M3.08%500.68M7.84%246.08M38.76%485.74M30.09%228.2M7.41%350.07M-9.33%175.43M-16.82%325.92M
Financing cost -698.80%-2.66M-166.58%-989K---333K---371K-----------------253.62%-3.56M----
Share of profits of associates 81.79%-3.7M33.88%-40.93M0.95%-20.3M-33.36%-61.91M-19.69%-20.49M-147.29%-46.42M-71.91%-17.12M-58.69%-18.77M-80.63%-9.96M15.80%-11.83M
Earning before tax 70.15%556.75M-5.55%414.06M45.05%327.21M-0.21%438.41M6.87%225.59M32.61%439.32M30.37%211.08M5.48%331.3M-13.40%161.91M-16.86%314.09M
Tax 10.78%-65.17M-10.70%-91.39M-35.85%-73.04M3.06%-82.56M-18.45%-53.77M-28.05%-85.16M-32.13%-45.39M-13.22%-66.51M5.99%-34.35M20.43%-58.74M
After-tax profit from continuing operations 93.41%491.58M-9.33%322.67M47.92%254.17M0.48%355.85M3.70%171.83M33.75%354.16M29.90%165.69M3.70%264.79M-15.20%127.55M-15.99%255.36M
Earning after tax 93.41%491.58M-9.33%322.67M47.92%254.17M0.48%355.85M3.70%171.83M33.75%354.16M29.90%165.69M3.70%264.79M-15.20%127.55M-15.99%255.36M
Minority profit 17.39%-1.46M-51.09%-3.33M-1,173.33%-1.77M45.01%-2.21M117.28%165K-20.23%-4.01M55.35%-955K-4,409.46%-3.34M---2.14M---74K
Profit attributable to shareholders 92.64%493.05M-8.95%326M49.10%255.94M-0.03%358.06M3.01%171.66M33.58%358.18M28.49%166.65M4.97%268.13M-13.78%129.69M-15.97%255.43M
Basic earnings per share 92.50%0.3286-9.00%0.217448.95%0.1707-0.13%0.23892.96%0.114637.79%0.239233.13%0.11137.09%0.1736-11.91%0.0836-15.40%0.1621
Diluted earnings per share 92.83%0.3282-8.94%0.21748.91%0.17020.34%0.23833.07%0.114336.89%0.237532.66%0.11097.03%0.1735-11.91%0.0836-15.40%0.1621
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data